Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (391-400 of 432) with videos related to

Pageof 44
Sort By:
Circulation. Arrhythmia and Electrophysiology|January 29, 2026
Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVCCorrado De Marco, Babken Asatryan, Anneline S J M Te Riele, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 30, 2021
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter studyMatteo Pagnesi, Riccardo M Inciardi, Carlo M Lombardi, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
Journal of the American College of Cardiology|July 20, 2019
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic DysfunctionEnrico Ammirati, Giacomo Veronese, Michela Brambatti, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
Pageof 44

Showing results (391-400 of 432) with videos related to

Sort By:
Pageof 44
Circulation. Arrhythmia and Electrophysiology|January 29, 2026
Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVCCorrado De Marco, Babken Asatryan, Anneline S J M Te Riele, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 30, 2021
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter studyMatteo Pagnesi, Riccardo M Inciardi, Carlo M Lombardi, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
Journal of the American College of Cardiology|July 20, 2019
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic DysfunctionEnrico Ammirati, Giacomo Veronese, Michela Brambatti, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
Pageof 44